Work

Interleukin-12 armored chimeric antigen receptor (CAR) T cells for heterogeneous antigen-expressing ovarian cancer.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.5_suppl.12

Authors: Oladapo O. Yeku, Terence Purdon, David R. Spriggs, Renier J. Brentjens

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2791617407

Cites:

Cited by: 9

Related to: 10